榴莲视频

AHA: Lower Better for Plaque Regression with PCSK9 Drugs

No diminishing returns at very low LDL levels in GLAGOV trial

Nov 15, 2016

AHA: Real World TAVR Is All About Patient Selection

Intermediate risk is a moving target

Nov 15, 2016

Statin 'Census' Shows Major Disparities

Women, minorities treated at significantly lower rates

Nov 14, 2016

AHA: Healthy Lifestyle Eases Heart Impact of High Genetic Risk

Fewer adverse events, less calcification in pooled data

Nov 13, 2016

AHA: No Cognitive Benefit from Heart Drugs in HOPE-3

Substudy finds mental function unimproved by BP, cholesterol treatments

Nov 13, 2016

AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilator

Investigational drug ularitide had no effect on mortality or clinical outcomes

Nov 13, 2016

AHA: Study Finds Celebrex Safe for Heart

But naproxen not as heart safe as believed

Nov 13, 2016

AHA: Multiple Listers for Transplants: Longer Wait, Lower Mortality

Disparity of organs by region a factor

Nov 12, 2015

SPRINT v. ACCORD: Which Target Will Win in Diabetes?

Not such a no-brainer, hypertension experts say

Nov 12, 2015

AHA: 3D Imaging May Mean Better Match for Pediatric Hearts

"Virtual transplant" could maximize use of donor hearts

Nov 10, 2015

AHA: Long-Acting Nitrate Flops in HFpEF

Study does not support the use of nitrates in subgroup of heart failure patients

Nov 08, 2015

AHA: No Excess Bleeding Risk with Dabigatran

LOS ANGELES -- Patients starting dabigatran (Pradaxa) did not have a higher risk of bleeding compared with new users of warfarin, according to a postmarketing data review by the FDA.

Nov 03, 2012

AHA: One or Two Drinks May Not Hurt Bypass Patients

CHICAGO -- Having an alcoholic drink does not appear to cause problems for patients following coronary artery bypass graft surgery -- but doctors warn that these patients cannot have more than one or two drinks a day.

Nov 16, 2010

AHA: Rivaroxaban Scores Win While Omega-3 Flops

CHICAGO -- Good news and not so good news about investigational treatments for atrial fibrillation are featured in this exclusive InFocus video report from the American Heart Association meeting.

Nov 15, 2010

AHA: FDA Drops Clopidogrel Bomb at AHA

ORLANDO -- The FDA has issued a public health advisory warning patients and physicians that concommitant use of clopidogrel (Plavix) and omeprazole (Prilosec and Prilosec OTC) blunts the antiplatelet effect of clopidogrel, so the combination should be avoided.

Nov 17, 2009

AHA: Some Statins May Disrupt Sleep

ORLANDO -- If patients taking simvastatin (Zocor) develop sleep disturbances, changing statins may be a good idea, researchers suggested here.

Nov 08, 2007